SecBot SecBot
144 ·Filed Apr 17, 2026

MLYS

Mineralys Therapeutics, Inc.
NEUTRAL
Impact 2/10
Horizondays Processed7mo ago SEC0001964306-26-000208
Form 144, notice of proposed sale of securities
Actionable Insight • Neutral

This is a routine, non-material sale by an officer; no immediate trading signal. Monitor for changes in volume or frequency, but current pattern suggests planned, periodic selling rather than a shift in sentiment.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$30.07
T+0 close · Apr 17, 2026 · via day close
Latest settled
−9.18%
T+60 · $27.31
Vs SPY
−15.96%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 20 $30.07entry
  2. T+1 · 7mo ago −4.29%α −3.64% · $28.78
  3. T+5 · 7mo ago −10.24%α −11.16% · $26.99
  4. T+20 · 6mo ago −12.24%α −16.44% · $26.39
  5. T+60 · 4mo ago −9.18%α −15.96% · $27.31
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

David Rodman, an officer of Mineralys Therapeutics, filed a Form 144 notifying intent to sell 416 shares of common stock, acquired via exercise of employee stock options. This is a routine, small-scale transaction consistent with prior regular sales.

Key Facts

  • Reporting person: David Rodman, Officer
  • Number of shares proposed for sale: 416
  • Nature of shares: Acquired through exercise of employee stock options
  • Method: Broker-assisted cashless exercise
  • Filing date: April 17, 2026
  • Recent pattern: Part of ongoing, regular small sales, 13 similar transactions in the past 6 months

Financial Impact

Approximately $13,000 (based on 13,033.28 from prior transaction on 04/17/2026)

insider ownershipshare count

Risk Factors

  • Minimal near-term selling pressure from this filing
  • Potential perception of lack of confidence if pattern accelerates, though current pace is normal

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001964306-26-000208
Document: 0001964306-26-000208-index.html0001964306-26-000208
Document: 0001964306-26-000208.txt0001964306-26-000208

Track record

35 reports on MLYS

Performance horizon

4 of 7 bullish or bearish reports moved the stock their way by T+20. Best: +20.97% at T+20 after the Jun 11, 2026 report. 5 of 10 went positive at some point.

Filters
  1. Nov 8, 20268d ago Press Release Bullish 6/10 Entry $15.81 Now $14.53 −8.10% settles Dec 8
  2. Nov 4, 202612d ago 8-K Neutral 4/10 Entry $15.24 Now $14.53 −4.66% settles Dec 4
  3. Nov 3, 202613d ago Institutional Cluster Neutral 2/10 Entry $15.99 Now $14.53 −9.13% settles Dec 2
  4. Oct 29, 202618d ago 8-K Bullish 6/10 Entry $18.18 Now $14.53 −20.08% settles Nov 30
  5. Oct 28, 202619d ago Press Release Bullish 6/10 Entry $21.38 Now $14.53 −32.04% settles Nov 25
  6. Oct 20, 202627d ago 3 Neutral 2/10 Entry $21.10 Now $14.53 −31.14% settles Nov 18
  7. Oct 20, 202627d ago 3 Neutral 2/10 Entry $21.10 Now $14.53 −31.14% settles Nov 18
  8. Oct 19, 202628d ago 8-K Neutral 2/10 Entry $21.58 Now $14.53 −32.67% settles Nov 17
  9. Oct 13, 20264w ago 144 Neutral 3/10 Entry $20.76 to $16.16 Now $14.53 −30.01% ▼ −22.16% −20.89% vs SPY
  10. Sep 30, 20266w ago 144 Neutral 3/10 Entry $23.72 to $21.24 Now $14.53 −38.74% ▼ −10.46% −11.16% vs SPY
Showing 10 of 35

US Market Status

Market Closed · Opens in 7h 52m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 17, 2026